[Federal Register Volume 70, Number 61 (Thursday, March 31, 2005)]
[Notices]
[Page 16506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-6331]



[[Page 16506]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Cardiovascular and Renal Drugs Advisory Committee; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is canceling the 
meeting of the Cardiovascular and Renal Drugs Advisory Committee 
scheduled for April 5, 2005. This meeting was announced in the Federal 
Register of March 9, 2005 (70 FR 11678).

FOR FURTHER INFORMATION CONTACT:  Cathy A. Groupe, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, e-mail: 
[email protected], or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area) code 3014512533.

    Dated: March 24, 2005.
Sheila Dearybury Walcoff,
Associate Commissioner for External Relations.
[FR Doc. 05-6331 Filed 3-25-05; 3:50 pm]
BILLING CODE 4160-01-S